 |
About IPG
Integrated Plant Genetics, Inc. (IPG) is a development stage biotechnology
company, in business to develop, produce and license new genetic technologies for the purpose of
horticultural, agricultural and forest tree improvement and disease control. The Company currently
provides gene engineering services to industry through research contracts and also disease resistance genes and
freedom-to-operate technologies, including plant transformation technologies and methods through our marketing
partners. We are currently devoping genetic technologies to make plants resistant
to diseases for which there is presently no or little resistance or tolerance. As IPG expands and its
technology improves, we anticipate licensing our improved genetic traits ("genetic software") to established
plant nurseries and seed producers.
IPG’s core technologies,
Disease Block and
Twin Block
represent a paradigm shift in scientific thinking about methods to control plant diseases.
Although traditional breeding methods have relied on plant resistance genes and natural
resistance mechanisms, it is a fact that most plant resistance genes have been defeated
by evolving pathogen populations. Recent success in the control of virus diseases of plants
by genetic engineering does not depend upon or even utilize traditional plant resistance genes.
Rather such control was achieved by first understanding the mechanism by which viruses caused
disease, and then blocking critical parts of the mechanism.
IPG’s core technologies, including plant transformation and disease resistance, provide the platforms for future development of specific
applications to control plant diseases. Some of these technologies are partly owned by the University of Florida and are exclusively
licensed to IPG for sublicensing.
Our History: IPG is a Delaware C-Corporation, founded and incorporated by Dr. Dean Gabriel in 1998. The Company became
a BDI Licensee in September, 1998.
Grants and Awards: IPG has been awarded five federal grants to further develop transgenic
plant technologies: two Phase I SBIR grant awards, one from USDA and the other from NSF. In
addition, IPG was awarded two grants from USDA's Animal and Plant Health Inspection Service (APHIS)
and a Phase II SBIR grant from NSF to develop citrus trees resistant to citrus canker disease.
For general inquiries, please send e-mail to
info@ipgenetics.com. For web site errors or content issues, please e-mail
webmaster@ipgenetics.com.
Copyright © 2001-2006 Integrated Plant Genetics, Inc. -- All Rights Reserved
|
|
|
|
